ISR Report Provides Insight into Pancreatic Cancer, Clinical Development Pipeline

Informing the drug development and commercialization industry Cary, N.C. – March 27, 2013 – Industry Standard Research (ISR) today announced the release of a new pharmaceutical market research report entitled “Pancreatic Cancer: Disease and Pipeline Analysis” which provides insight into a market with few effective therapies. “ISR’s latest report profiles the pancreatic cancer market because … Continued

ISR Reports Breaks Down: 2013 Late Phase Market Overview and Outlook

ISR’s reports have been featured in numerous industry publications and news sources over the years. Below is a link to Appliedclinicaltrialsonline.com’s: “ISR Reports Breaks Down: 2013 Late Phase Market Overview and Outlook” https://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Blogs/ISR-Reports-Breaks-Down-2013-Late-Phase-Market-Ove/ArticleStandard/Article/detail/807543

Influence of Cost in the CRO Selection Process

ISR’s reports have been featured in numerous industry publications and news sources over the years. Below is a link to Appliedclinicaltrialsonline.com’s: “Influence of Cost in the CRO Selection Process” https://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Influence-of-Cost-in-the-CRO-Selection-Process/ArticleStandard/Article/detail/808507

ISR CUSTOMERS